Revenue decreased 15.2%
Revenue changed -15.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -15.2% from the comparable as-filed period.
Gross profit changed -19.9% from the comparable as-filed period.
R&D / revenue changed -2148 basis points from the comparable as-filed period.
Receivables / revenue changed -1932 basis points from the comparable as-filed period.
Working capital changed -15.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed -15.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed +10.3% from the comparable as-filed period.
Inventory changed -1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +40 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.